erratum · Journal of Neurology

Correction to: The impact of metformin use on the outcomes of relapse‑remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open‑label randomized controlled trial

Mohamed Y. Abdelgaied
Mohamed Hamed Rashad
Hend Mohamed El-Tayebi
Mohamed H. Solayman

20241 citationOpen accessAin Shams University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Chronic Myeloid Leukemia Treatments
Chronic Lymphocytic Leukemia Research
Multiple Sclerosis Research Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s00415-024-12249-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.